Triclosan resistance in Salmonella enterica serovar Typhimurium

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 1, 2008, Pages 83-91

  Webber, Mark A ^a   Randall, Luke P ^b   Cooles, Susan ^b   Woodward, Martin J ^b   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Biocides; Efflux; Fitness

Indexed keywords

BACTERIAL PROTEIN; PROTEIN ACRAB; PROTEIN ACRB; PROTEIN FABL; TOLC PROTEIN; TRICLOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM MUTANT; CHICKEN; CONTROLLED STUDY; CORRELATION FUNCTION; DISINFECTION; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC COMPLEMENTATION; GENOTYPE; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; NONHUMAN; PHENOTYPE; SALMONELLA TYPHIMURIUM; WILD TYPE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; GENE DELETION; GENETIC COMPLEMENTATION TEST; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, INSERTIONAL; MUTATION; SALMONELLA TYPHIMURIUM; TRICLOSAN;

EID: 45749116550     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn137     Document Type: Article

References (37)

1. Roberts JA, Cumberland P, Sockett PN et al. The study of infectious intestinal disease in England: Socio-economic impact. Epidemiol Infect 2003; 130: 1-11.
2. Weill FX, Lailler R, Praud K et al. Emergence of extended-spectrum-β-lactamase (CTX-M-9)-producing multiresistant strains of Salmonella enterica serotype Virchow in poultry and humans in France. J Clin Microbiol 2004; 42: 5767-73.
3. Carraminana JJ, Rota C, Agustin I et al. High prevalence of multiple resistance to antibiotics in Salmonella serovars isolated from a poultry slaughterhouse in Spain. Vet Microbiol 2004; 104 133-9.
4. Michael GB, Butaye P, Cloeckaert A et al. Genes and mutations conferring antimicrobial resistance in Salmonella: An update. Microbes Infect 2006; 8: 1898-914.
5. Fluit AC. Towards more virulent and antibiotic-resistant Salmonella? FEMS Immunol Med Microbiol 2005; 43: 1-11.
6. Helms M, Vastrup P, Gerner-Smidt P et al. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002; 8: 490-5.
7. Piddock LJ. Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 2006; 4: 629-36.
8. Giraud E, Cloeckaert A, Kerboeuf D et al. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000; 44: 1223-8.
9. Baucheron S, Imberechts H, Chaslus-Dancla E et al. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb Drug Resist 2002; 8: 281-9.
10. Baucheron S, Mouline C, Praud K et al. TolC but not AcrB is essential for multidrug-resistant Salmonella enterica serotype Typhimurium colonization of chicks. J Antimicrob Chemother 2005; 55: 707-12.
11. Buckley AM, Webber MA, Cooles S et al. The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 2006; 8: 847-56.
12. Ricci V, Tzakas P, Buckley A et al. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother 2006; 50: 38-42.
13. Russell AD. Biocide use and antibiotic resistance: The relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis 2003; 3: 794-803.
14. Medlin J. Germ warfare. Environ Health Perspect 1997; 105: 290-2.
15. Cutter CN. The effectiveness of triclosan-incorporated plastic against bacteria on beef surfaces. J Food Prot 1999; 62: 474-9.
16. Moretro T, Sonerud T, Mangelrod E et al. Evaluation of the antibacterial effect of a triclosan-containing floor used in the food industry. J Food Prot 2006; 69: 627-33.
17. Aiello AE, Larson EL, Levy SB. Consumer antibacterial soaps: Effective or just risky? Clin Infect Dis 2007; 45 Suppl 2: S137-47.
18. Kolpin DW, Furlong ET, Meyer MT et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ Sci Technol 2002; 36: 1202-11.
19. Singer H, Muller S, Tixier C et al. Triclosan: Occurrence and fate of a widely used biocide in the aquatic environment: Field measurements in wastewater treatment plants, surface waters, and lake sediments. Environ Sci Technol 2002; 36: 4998-5004.
20. Allmyr M, Adolfsson-Erici M, McLachlan MS et al. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ 2006; 372: 87-93.
21. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998; 394: 531-2.
22. Heath RJ, Su N, Murphy CK et al. The enoyl-[acyl-carrier-protein] reductases Fabl and FabL from Bacillus subtilis. J Biol Chem 2000; 275: 40128-33.
23. Sivaraman S, Zwahlen J, Bell AF et al. Structure-activity studies of the inhibition of Fabl, the enoyl reductase from Escherichia coli by triclosan: Kinetic analysis of mutant Fabls. Biochemistry 2003; 42: 4406-13.
24. Chuanchuen R, Karkhoff-Schweizer RR, Schweizer HP. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am J Infect Control 2003; 31: 124-7.
25. McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1998; 166: 305-9.
26. Van der Straaten T, Janssen R, Mevius DJ et al. Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2004; 48: 2202-4.
27. Tabak M, Scher K, Hartog E et al. Effect of triclosan on Salmonella typhimurium at different growth stages and in biofilms. FEMS Micrabiol Lett 2007; 267: 200-6.
28. Turner AK, Nair S, Wain J. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother 2006; 58 733-40.
29. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
30. Wang RF, Kushner SR. Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 1991; 100: 195-9.
31. Mortimer PG, Picklock LJ. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 1991; 28: 639-53.
32. Eaves DJ, Ricci V, Piddock LJ. Expression of acrB, acrF, acrD, marA and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob Agents Chemother 2004; 48: 1145-50.
33. Fan F, Yan K, Wallis NG et al. Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 3343-7.
34. Graeme-Cook KA, May G, Bremer E et al. Osmotic regulation of porin expression: A role for DNA supercoiling. Mol Microbiol 1989; 3 1287-94.
35. Oethinger M, Kern WV, Jellen-Ritter AS et al. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 2000; 44: 10-3.
36. Wray C, Sojka WJ. Experimental Salmonella typhimurium infection in calves. Res Vet Sci 1978; 25: 139-43.
37. Randall LP, Eaves DJ, Cooles SW et al. Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression. J Antimicrob Chemother 2005; 56 297-306.